Renalytix Share Discussion Threads

[charlieej] 24/9/2020 16:21

They have significant cash, should have FDA approval this year, will have a share in the first test to give levels of antibodies (when finally approved) hopefully soon, and on top of which there are sure to be plenty of deals being worked on in the background. I'd be amazed if it's not significantly higher by Christmas. The company has not failed to deliver on anything bar the antibody test which they are only a minority shareholder in and it was always brave to try and predict the FDA turnaround time on a new form of test. This isn't particularly liquid so down moves and up moves will be exaggerated.

[mr roper] 24/9/2020 15:54

They have the cash, just need to bring in the revenue now. Folk ain’t getting slimmer in the US so it’s a hold until they do...

[nimbo1] 24/9/2020 13:52

I think the main problem is Uk follows Nasdaq price, but US still sees it as a Uk business and no one cares about it yet. Revenue and news flow will change that but takes time so can get uncomfortable in turbulent markets!

Anyway they have the money they need to achieve great things so is an opportunity for new purchasers imo

[wan] 24/9/2020 08:48

In my opinion only, shares are starting to reflect the spin-off of Verici (and may be a bit for the delays). But, given the opportunity, very content to apply, at the very least, a strong hold appraisal.

[nimbo1] 24/9/2020 08:27

this has certainly lost its mojo for now. A chance to accumulate on the 200 dma I would probably take!

[74tom] 23/9/2020 09:08

Interesting... do you have a link to their article or wherever it was disclosed? £25m would be an attractive entry level in the current pharma environment...

[sspurt] 22/9/2020 20:27

N+1 Singer
Expected mkt cap £22-25m

[sspurt] 22/9/2020 17:02

Verici IPO scheduled for week beginning 26 Oct. they are hoping to price 16 Oct or thereabouts.

[wan] 22/9/2020 08:11

The positive news flow continues, with another important step realised.

[matrixtrader] 18/9/2020 21:24

I am not sure it is revenue generating or relevant to renalytix actually. The mount Sinai test is exactly that. A mount Sinai test who are a separate entity to renx. The kantaro JV is a way of commercialising and then distributing the test and they included renx in in that. Bio techne do the distribution . So it's relevant in the fact that New York health think it's valid and useable but only by mount Sinai. So hopefully fda will eua it for use outside of mount Sinai and that's where the jv and revenue kicks in I believe but not sure what taking fda so long when they have already approved it within mount Sinai

[74tom] 18/9/2020 16:41

Zero need for the aggression faz, it doesn't benefit anyone! I look forward to it listing, and it'll be a nice distraction from the current sluggish performance of RENX since the NASDAQ listing. Not that it matters, revenues will now flow & the share price will follow.

I am slightly confused as to why they haven't RNS'd the New York EUA of the Kantaro test - granted it's not the FDA but its still noteworthy (and revenue generating). We are surely due a full update, maybe with the half year results?

[nimbo1] 18/9/2020 15:55

I’ll post what I like on a free bb - not like your posts add any value either! Just filter me if my odd comment offends you. I’ve done likewise.

[faz] 18/9/2020 15:11

NImbo there's enough previous posts about Verici and whether it can be credited to accounts. Just read them. Or call your broker instead of telling us they are useless.

[nimbo1] 18/9/2020 14:54

im not worried they'll show of course - we are the legal owners - just nice to have : )

[toffeeman] 18/9/2020 14:27

Verici - AJBell also not showing

[nimbo1] 18/9/2020 13:38

That’s exciting about verici listing - Hargreaves still haven’t credited my account with the shares! F’ing useless

[toffeeman] 18/9/2020 10:58

Seems to have been in auction quite a bit this am

[wan] 18/9/2020 07:46

Newly launched product website added to header -

[wan] 18/9/2020 07:36

Very encouraging news flow, with more in the coming weeks/months it would seem.

[74tom] 18/9/2020 07:36

Brilliant find Homebrewruss, didn’t expect a September listing - but then again after a NASDAQ IPO, listing on AIM must be a piece of cake!

[mr roper] 18/9/2020 07:30

“RenalytixAI expects revenue generation to increase in the near-term“

All coming together

[donald pond] 18/9/2020 07:23

I wonder whether there are some things that need to be co-ordinated with news to the NYSE?